The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: Insights from a meta-analysis

European Journal of Heart Failure

Volumn 16, Issue 12, 2014, Pages 1317-1322

  Cheng, Min ^a   Lu, Xiangfeng ^a   Huang, Jianfeng ^a   Zhang, Jian ^a   Zhang, Shu ^a   Gu, Dongfeng ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Hazard ratio; Mortality; Preserved LVEF

Indexed keywords

ARTICLE; CARDIOVASCULAR MORTALITY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PROGNOSIS; SENSITIVITY ANALYSIS; AGED; ATRIAL FIBRILLATION; FEMALE; HEART STROKE VOLUME; MALE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SURVIVAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; STROKE VOLUME; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84913584850     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.187     Document Type: Article

References (35)

1. Anter E, Jessup M, Callans DJ,. Atrial fibrillation and heart failure: treatment considerations for a dual epidemic. Circulation. 2009; 119: 2516-2525.
2. Braunwald E,. Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 1997; 337: 1360-1369.
3. Middlekauff HR, Stevenson WG, Stevenson LW,. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 1991; 84: 40-48.
4. Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN,. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group. Circulation. 1993; 87 (6 Suppl): VI102-VI110.
5. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R, Singh SN,. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 1998; 98: 2574-2579.
6. Makubi A, Hage C, Lwakatare J, Kisenge P, Makani J, Ryden L, Lund LH,. Contemporary aetiology, clinical characteristics and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: the prospective Tanzania Heart Failure (TaHeF) study. Heart 2014; 100: 1235-1241.
7. Olsson LG, Swedberg K, Ducharme A, Granger CB, Michelson EL, McMurray JJ, Puu M, Yusuf S, Pfeffer MA,. Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol 2006; 47: 1997-2004.
8. Linssen GC, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL, van Veldhuisen DJ,. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 2011; 13: 1111-1120.
9. Pedersen OD, Sondergaard P, Nielsen T, Nielsen SJ, Nielsen ES, Falstie-Jensen N, Nielsen I, Kober L, Burchardt H, Seibaek M, Torp-Pedersen C,. Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. Eur Heart J. 2006; 27: 2866-2870.
10. Corell P, Gustafsson F, Schou M, Markenvard J, Nielsen T, Hildebrandt P,. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. Eur J Heart Fail 2007; 9: 258-265.
11. Eapen ZJ, Greiner MA, Fonarow GC, Yuan Z, Mills RM, Hernandez AF, Curtis LH,. Associations between atrial fibrillation and early outcomes of patients with heart failure and reduced or preserved ejection fraction. Am Heart J 2014; 167: 369-375.
12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
13. Altman DG, Bland JM,. Interaction revisited: the difference between two estimates. BMJ 2003; 326: 219.
14. McManus DD, Hsu G, Sung SH, Saczynski JS, Smith DH, Magid DJ, Gurwitz JH, Goldberg RJ, Go AS,. Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction. J Am Heart Assoc 2013; 2: e005694.
15. Zakeri R, Chamberlain AM, Roger VL, Redfield MM,. Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation 2013; 128: 1085-1093.
16. Ahmed MI, White M, Ekundayo OJ, Love TE, Aban I, Liu B, Aronow WS, Ahmed A,. A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study. Eur Heart J. 2009; 30 (16):2029-2037.
17. Khazanie P, Liang L, Qualls LG, Curtis LH, Fonarow GC, Hammill BG, Hammill SC, Heidenreich PA, Masoudi FA, Hernandez AF, Piccini JP,. Outcomes of medicare beneficiaries with heart failure and atrial fibrillation. JACC Heart Fail 2014; 2: 41-48.
18. Chamberlain AM, Redfield MM, Alonso A, Weston SA, Roger VL,. Atrial fibrillation and mortality in heart failure: a community study. Circ Heart Fail 2011; 4: 740-746.
19. Mahoney P, Kimmel S, DeNofrio D, Wahl P, Loh E,. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol 1999; 83: 1544-1547.
20. Raunsø J, Pedersen OD, Dominguez H, Hansen ML, Moller JE, Kjaergaard J, Hassager C, Torp-Pedersen C, Kober L,. Atrial fibrillation in heart failure is associated with an increased risk of death only in patients with ischaemic heart disease. Eur J Heart Fail 2010; 12: 692-697.
21. Gotsman I, Zwas D, Planer D, Azaz-Livshits T, Admon D, Lotan C, Keren A,. Clinical outcome of patients with heart failure and preserved left ventricular function. Am J Med 2008; 121: 997-1001.
22. Shotan A, Garty M, Blondhein DS, Meisel SR, Lewis BS, Shochat M, Grossman E, Porath A, Boyko V, Zimlichman R, Caspi A, Gottlieb S,. Atrial fibrillation and long-term prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS). Eur Heart J 2010; 31: 309-317.
23. Zafrir B, Paz H, Wolff R, Salman N, Merhavi D, Lewis BS, Amir O,. Mortality rates and modes of death in heart failure patients with reduced versus preserved systolic function. Eur J Intern Med 2011; 22: 53-56.
24. Baldasseroni S, Orso F, Fabbri G, De Bernardi A, Cirrincione V, Gonzini L, Fumagalli S, Marchionni N, Midi P, Maggioni AP,. Age-dependent prognostic significance of atrial fibrillation in outpatients with chronic heart failure: data from the Italian Network on Congestive Heart Failure Registry. Cardiology 2010; 116: 79-88.
25. Testa G, Cacciatore F, Della-Morte D, Galizia G, Mazzella F, Gargiulo G, Langellotto A, D'Ambrosio D, Ferrara N, Rengo F, Abete P,. Role of permanent atrial fibrillation (AF) on long-term mortality in community-dwelling elderly people with and without chronic heart failure (CHF). Arch Gerontol Geriatr 2012; 55: 91-95.
26. Rusinaru D, Leborgne L, Peltier M, Tribouilloy C,. Effect of atrial fibrillation on long-term survival in patients hospitalised for heart failure with preserved ejection fraction. Eur J Heart Fail 2008; 10: 566-572.
27. Ahmed A, Thornton P, Perry GJ, Allman RM, DeLong JF,. Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure. Eur J Heart Fail 2004; 6: 421-6.
28. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ,. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 2003; 107: 2920-2925.
29. Maisel WH, Stevenson LW,. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol 2003; 91: 2D-8D.
30. Kannel WB, Abbott RD, Savage DD, McNamara PM,. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982; 306: 1018-1022.
31. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW,. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998; 32: 695-703.
32. Mamas MA, Caldwell JC, Chacko S, Garratt CJ, Fath-Ordoubadi F, Neyses L,. A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail 2009; 11: 676-83.
33. Pozzoli M, Cioffi G, Traversi E, Pinna GD, Cobelli F, Tavazzi L,. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: a prospective study in 344 patients with baseline sinus rhythm. J Am Coll Cardiol 1998; 32: 197-204.
34. Gosselink AT, Crijns HJ, van den Berg MP, van den Broek SA, Hillege H, Landsman ML, Lie KI,. Functional capacity before and after cardioversion of atrial fibrillation: a controlled study. Br Heart J 1994; 72: 161-166.
35. Grönefeld GC, Mauss O, Li YG, Klingenheben T, Hohnloser SH,. Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol 2000; 11: 1208-1214.